🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchCan we talk about how SLOW the FDA is — my results so far Page 8

Can we talk about how SLOW the FDA is — my results so far

NurseAsh_DET Tue, Nov 18, 2025 at 7:47 PM 43 replies 1,294 viewsPage 8 of 9
Dr.Martinez
Medical Advisor
3,891
28,456
Nov 2023
Boston, MA
Online
Mar 22, 2026 at 4:22 PM#36
PeptideChemSF said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

There is a second half to this that has not been said yet. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

Last edited: Mar 22, 2026 at 9:22 PM
17 15AttorneyGrant, DebRD_ATL, KristenIndy and 14 others
Reply Quote Save Share Report
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Mar 29, 2026 at 3:08 PM#37

One concrete data point for the thread. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

I would rather be corrected than agreed with, if it comes to it.

18 16mike_nyc, VendorMark, COA_Karl and 15 others
Reply Quote Save Share Report
zoe_NC
Member
278
1,234
Nov 2024
Charlotte, NC
Apr 5, 2026 at 1:50 PM#38

A narrower follow-up, since the general answer is now clear:

What did you change at the same time, and can you separate the two now?

Last edited: Apr 5, 2026 at 2:50 PM
19 17james_edin, FranDenver, Dr.BariatricHTX and 16 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
cory_ATX
Member
456
2,123
Jul 2024
Austin, TX
Apr 12, 2026 at 12:27 PM#39
DataDave said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Pushing back on DataDave here. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.

I would rather be corrected than agreed with, if it comes to it.

20 18Dr.PathRoch, mona_PHX, andrew_nyc and 17 others
Reply Quote Save Share Report
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
Apr 19, 2026 at 11:01 AM#40
DataDave said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Agreed, with the usual condition: that holds for the average and this board is a collection of individuals. A population claim and a personal prediction are different things and get quoted interchangeably.

42 15B12Beth, RickReta_CO, PharmHunterJen and 39 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register